Ginkgo Bioworks Holdings (DNA) Asset Utilization Ratio (2021 - 2026)
Ginkgo Bioworks Holdings' (DNA) quarterly Asset Utilization Ratio came in at 0.11 in Q2 2026, down 33.61% on a YoY basis from 0.17 in Q2 2025, and down 9.03% quarter-over-quarter from 0.12 in Q1 2026.
Analysis
Ginkgo Bioworks Holdings (DNA) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Asset Utilization Ratio for 6 consecutive years, with 0.11 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Asset Utilization Ratio fell 33.61% year-over-year to 0.11; the trailing twelve-month figure through Jun 2026 stood at 0.11 (down 33.61% YoY), and the FY2025 full-year result was 0.14, down 8.68% from the prior year.
- Asset Utilization Ratio declined to 0.11 in Q2 2026 per DNA's latest filing, from 0.12 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.27 in Q3 2024 and bottomed at 0.11 in Q2 2026.
- Historically, Asset Utilization Ratio has averaged 0.19 across 5 years, with a median of 0.17 in 2025.
- The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio jumped 245.3% in 2022, then plunged 51.81% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.22 in 2022, then increased by 14.98% to 0.25 in 2023, then slumped by 36.22% to 0.16 in 2024, then retreated by 18.43% to 0.13 in 2025, then fell by 14.66% to 0.11 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.11, 0.12, and 0.13 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 0.57 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 1.33 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 0.50 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 0.52 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 0.99 |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 0.11 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 2.01 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 0.84 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 0.02 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.11 |
| Mar 31, 2026 | 0.12 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | 0.13 |
| Jun 30, 2025 | 0.17 |
| Mar 31, 2025 | 0.17 |
| Dec 31, 2024 | 0.16 |
| Sep 30, 2024 | 0.27 |
| Jun 30, 2024 | 0.24 |
| Mar 31, 2024 | 0.26 |
| Dec 31, 2023 | 0.25 |
| Sep 30, 2023 | 0.15 |
| Jun 30, 2023 | 0.14 |
| Mar 31, 2023 | 0.16 |
| Dec 31, 2022 | 0.22 |
| Sep 30, 2022 | 0.27 |
| Jun 30, 2022 | 0.27 |
| Mar 31, 2022 | 0.21 |
| Dec 31, 2021 | 0.15 |
| Sep 30, 2021 | 0.10 |